Home4506 • TYO
Sumitomo Pharma Co Ltd
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 112.43B | 36.47% |
Operating expense | 49.59B | -38.60% |
Net income | 53.45B | 206.97% |
Net profit margin | 47.54 | 178.38% |
Earnings per share | — | — |
EBITDA | 27.47B | 226.91% |
Effective tax rate | 5.29% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 85.39B | 134.23% |
Total assets | 852.12B | -19.61% |
Total liabilities | 686.00B | -4.24% |
Total equity | 166.12B | — |
Shares outstanding | 397.29M | — |
Price to book | 1.77 | — |
Return on assets | 6.48% | — |
Return on capital | 10.25% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 53.45B | 206.97% |
Cash from operations | 939.00M | 101.67% |
Cash from investing | -8.00M | -100.14% |
Cash from financing | -15.87B | -158.08% |
Net change in cash | -13.69B | 42.82% |
Free cash flow | -4.83B | 89.51% |
Previous close
¥738.00
Day range
¥738.00 - ¥756.00
Year range
¥279.00 - ¥838.00
Market cap
297.23B JPY
Avg Volume
2.01M
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
About
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
Founded
May 14, 1897
Headquarters
Website
Employees
4,980
